Johnson & Johnson (JNJ) Tops Q2 EPS by 4c; raises guidance
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $262.08 --0%
Financial Fact:
CASH DIVIDENDS PER SHARE: 0.8
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
CASH DIVIDENDS PER SHARE: 0.8
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $2.90, $0.04 better than the analyst estimate of $2.86. Revenue for the quarter came in at $25.31 billion versus the consensus estimate of $25.02 billion.
GUIDANCE:
Johnson & Johnson sees FY2026 EPS of $11.50-$11.65, versus the consensus of $11.58. Johnson & Johnson sees FY2026 revenue of $100.8-101.4 billion, versus the consensus of $101.06 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- RCM Technologies (RCMT) Tops Q2 EPS by 17c
- Agora Inc. (API) PT Raised to $6.80 at BofA Securities
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
